Eribulin Mesylate Solution For Injection Price And Quantity
100 Unit
Eribulin Mesylate Solution For Injection Product Specifications
24-36 Months
(20C to 25C or 68F to 77F)
Injection
Eribulin Mesylate Solution For Injection Trade Information
Cash in Advance (CID)
5000 Unit Per Month
7-10 Days
Asia Australia Central America North America South America Eastern Europe Western Europe Middle East Africa
All India
Product Description
Eribulin Mesylate Solution for Injection is a medication used for the treatment of metastatic breast cancer. It contains Eribulin Mesylate as the active ingredient. This injection is available in dosage form and has a shelf life of 24-36 months. The storage instructions for this product are to keep it at a temperature between 20C to 25C or 68F to 77F. This medication works by inhibiting the process of cell division and growth, ultimately leading to the death of cancer cells. It is administered through injection and is prescribed by a healthcare professional.
FAQs of Eribulin Mesylate Solution For Injection:
Q: What is the use of this medication?
A: This medication is used for the treatment of metastatic breast cancer.
Q: What is the active ingredient in this product?
A: The active ingredient in this product is Eribulin Mesylate.
Q: What is the dosage form of this medication?
A: This medication is available in the form of an injection.
Q: What are the storage instructions for this product?
A: This product should be stored between 20C to 25C or 68F to 77F.
Q: How long is the shelf life of this medication?
A: The shelf life of this medication is 24-36 months.